Determining Minimum Effective Polymer Concentration for ASD Using Crystal16

Dr. Sharmistha Pal is leading the solid form screening team in Dr. Reddy's Laboratories. She has more than 20 years of experience in the pharmaceutical industry working in area of solid form development, manufacturing and characterization. Her expertise is in the field of developing and modulating physicochemical and bulk properties of API through solid form transformations and crystallization processes to address challenges in formulation and bioavailability within regulatory framework. Prior to joining Dr. Reddy's Lab, she worked in different scientific roles at leading big pharma and CROs like Eli Lilly &Co., AstraZeneca India, and Biocon Bristol Myers Squibb Research Center (BBRC). She holds Ph.D. in Pharmaceutics from University of Minnesota.

Jayshree Raju Borade is working as Polymorph Scientist in the Polymorph Screening Team at Dr. Reddy’s Laboratories, with 2.5 years of experience in the pharmaceutical industry. She holds a Master’s degree in Pharmaceutics from NIPER Mohali and actively contributes to advancing solid‑form understanding in drug development.